Amphastar Pharmaceuticals ROA 2012-2026 | AMPH
Current and historical return on assets (ROA) values for Amphastar Pharmaceuticals (AMPH) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Amphastar Pharmaceuticals ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2026-03-31 | $0.08B | $1.64B | 4.76% |
| 2025-12-31 | $0.10B | $1.63B | 5.94% |
| 2025-09-30 | $0.11B | $1.62B | 6.85% |
| 2025-06-30 | $0.13B | $1.59B | 8.42% |
| 2025-03-31 | $0.14B | $1.56B | 9.04% |
| 2024-12-31 | $0.16B | $1.55B | 10.28% |
| 2024-09-30 | $0.16B | $1.53B | 10.25% |
| 2024-06-30 | $0.17B | $1.53B | 10.84% |
| 2024-03-31 | $0.15B | $1.50B | 10.25% |
| 2023-12-31 | $0.14B | $1.30B | 10.52% |
| 2023-09-30 | $0.14B | $1.11B | 12.16% |
| 2023-06-30 | $0.10B | $0.91B | 11.27% |
| 2023-03-31 | $0.09B | $0.74B | 12.54% |
| 2022-12-31 | $0.09B | $0.73B | 12.51% |
| 2022-09-30 | $0.08B | $0.71B | 10.85% |
| 2022-06-30 | $0.09B | $0.69B | 13.17% |
| 2022-03-31 | $0.08B | $0.68B | 12.12% |
| 2021-12-31 | $0.06B | $0.66B | 9.56% |
| 2021-09-30 | $0.04B | $0.65B | 5.70% |
| 2021-06-30 | $0.01B | $0.64B | 1.72% |
| 2021-03-31 | $0.00B | $0.62B | 0.48% |
| 2020-12-31 | $0.00B | $0.61B | 0.33% |
| 2020-09-30 | $0.01B | $0.59B | 1.18% |
| 2020-06-30 | $0.00B | $0.59B | 0.68% |
| 2020-03-31 | $0.05B | $0.59B | 8.86% |
| 2019-12-31 | $0.05B | $0.58B | 8.45% |
| 2019-09-30 | $0.05B | $0.56B | 9.26% |
| 2019-06-30 | $0.05B | $0.54B | 9.90% |
| 2019-03-31 | $0.00B | $0.50B | 0.40% |
| 2018-12-31 | $-0.01B | $0.47B | -1.27% |
| 2018-09-30 | $-0.01B | $0.46B | -1.53% |
| 2018-06-30 | $-0.01B | $0.45B | -2.01% |
| 2018-03-31 | $0.00B | $0.45B | -0.90% |
| 2017-12-31 | $0.00B | $0.44B | 0.90% |
| 2017-09-30 | $0.00B | $0.44B | 0.00% |
| 2017-06-30 | $0.00B | $0.43B | 0.92% |
| 2017-03-31 | $0.01B | $0.43B | 2.12% |
| 2016-12-31 | $0.01B | $0.42B | 2.41% |
| 2016-09-30 | $0.02B | $0.41B | 5.18% |
| 2016-06-30 | $0.01B | $0.40B | 3.52% |
| 2016-03-31 | $0.00B | $0.40B | 0.00% |
| 2015-12-31 | $0.00B | $0.40B | -0.76% |
| 2015-09-30 | $-0.01B | $0.40B | -3.54% |
| 2015-06-30 | $-0.02B | $0.40B | -4.04% |
| 2015-03-31 | $-0.01B | $0.40B | -2.53% |
| 2014-12-31 | $-0.01B | $0.38B | -2.87% |
| 2014-09-30 | $-0.01B | $0.37B | -1.62% |
| 2014-06-30 | $0.00B | $0.27B | -0.37% |
| 2014-03-31 | $0.01B | $0.17B | 4.68% |
| 2013-12-31 | $0.01B | $0.09B | 14.16% |
| 2013-09-30 | $0.01B | $0.08B | 17.67% |
| 2013-06-30 | $0.02B | $0.08B | 21.45% |
| 2013-03-31 | $0.01B | $0.08B | 17.67% |
| 2012-12-31 | $0.02B | $0.08B | 22.71% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.924B | $0.720B |
| Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Bausch Health Cos (BHC) | Canada | $2.086B | 1.50 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |